HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German Hemp Manufacturer Blasts Food Safety Regulator Over CBD Statement

Executive Summary

Germany's Federal Office of Consumer Protection and Food Safety (BVL) is accused of issuing false and legally questionable advice with regards to cannabidiol (CBD) food supplements by hemp manufacturer MH Medical Hemp GmbH.

You may also be interested in...



Unauthorized CBD Sold In Europe Most Likely To Originate From UK

The UK was the most likely source of unauthorized CBD food products sold in the EU in the first half of 2020, an analysis by HBW Insight reveals. Ireland and Spain are leading the way in cracking down on such products and informing neighboring countries of the risks posed.

Germany And Sweden Leading The EU In CBD Enforcement Action

Sweden and Germany are cracking down on unauthorized CBD food products and warning their neighbors of the health risks posed to consumers, an analysis by HBW Insight reveals. A large proportion of these CBD products are being sold as food supplements and many originate from the Netherlands. 

Cannabis Trade Group Threatens FSA With Legal Action As CBD Novel Food Row Intensifies

Cannabis trade association CannaPro is threatening legal action against the UK's Food Standards Agency for its response to moves by EU regulators to classify CBD as a novel Food. The FSA's handling of the situation is negatively impacting business, states CannaPro, which has warned the agency it will sue for damages.  

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148708

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel